地加瑞克 (Firmagon, Degarelix Accord)

Degarelix

未知生产厂商

Degarelix is a GnRH receptor antagonist used in the management of advanced prostate cancer.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Degarelix is a GnRH receptor antagonist used in the management of advanced prostate cancer.

作用机制

Degarelix competitively inhibits GnRH receptors in the pituitary gland, preventing the release of luteinizing hormone (LH) and follicle stimulating hormone. Reduced LH suppresses testosterone release, which slows the growth and reduces the size of prostate cancers.

适应症

Degaralix is used for the management of advanced prostate cancer.

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Treatment of metastatic stage prostate cancer with degarelix
EP 2650012 B1申请人: FERRING BV优先权: 2008
CN
EP
US
WO
28 件公开
MANUFACTURE OF DEGARELIX
EP 2854831 B1申请人: FERRING BV优先权: 2012
CN
EP
US
WO
17 件公开
METHOD FOR ANALYZING DEGARELIX AND ASSOCIATED PRODUCTS
EP 4069863 A4申请人: FRESENIUS KABI USA LLC优先权: 2019
CN
EP
US
WO
4 件公开
DEGARELIX ORGANIC SOLVENT FORMULATIONS
EP 4661841 A1申请人: TOLMAR INTERNATIONAL LTD优先权: 2023
CN
EP
US
WO
4 件公开
PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES
- EP 3981781 A1
  申请人: FRESENIUS KABI IPSUM S R L优先权: 2015
  CN
  EP
  US
  4 件公开
- US 9090656 B2
  申请人: RASMUSSEN JON HOLBECH优先权: 2010
  EP
  US
  4 件公开
- US 9260480 B2
  申请人: KALITA DIPAK优先权: 2010
  US
  2 件公开
COMPOSITIONS, KITS AND METHODS FOR TREATING BENIGN PROSTATE HYPERPLASIA
US 2011039787 A1申请人: FERRING INT CT SA优先权: 2010
CN
US
3 件公开
PROCESS FOR THE PREPARATION OF DEGARELIX
US 2022177521 A1申请人: FRESENIUS KABI IPSUM S R L优先权: 2019
CN
US
2 件公开
Prevention of diabetes and prolongation of the honeymoon phase of diabetes by administration of GnRH antagonists
US 2003045475 A1申请人: JACOBSON JILL D优先权: 2002
US
2 件公开
Method for the manufacture of degarelix
US 8828938 B2申请人: POLYPEPTIDE LABORATORIES AS优先权: 2009
US
2 件公开
Pharmaceutical compositions and methods for the treatment of prostate cancer
US 8722088 B2申请人: OLESEN TINE KOLD优先权: 2010
US
2 件公开

药物

地加瑞克 (Firmagon, Degarelix Accord)

概览

作用机制

适应症

相关疾病

专利

PROCESS FOR THE MANUFACTURE OF DEGARELIX AND ITS INTERMEDIATES